Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.

The aim of the present study was to test whether the combination of a beta-lactam drug plus an aminoglycoside has advantage over monotherapy for severe gram-negative infections. Of 2,124 patients with gram-negative bacteremia surveyed prospectively, 670 were given inappropriate empirical antibiotic...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Leibovici, L, Paul, M, Poznanski, O, Drucker, M, Samra, Z, Konigsberger, H, Pitlik, S D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163862/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145881/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.1127
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!